Sullivan Lynne Marie
SEC insider (Form 3/4/5 filer). CIK 0001727640. Director at Solid Biosciences Inc. (SLDB) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in CHARLESTOWN, MA.
Companies Sullivan Lynne Marie has filed insider reports for
- Solid Biosciences Inc. (SLDB): Director
- Inozyme Pharma, Inc. (INZY): Director
- Unity Biotechnology, Inc. (UBX): Officer, CFO & Head of Corp. Dev.
Sullivan Lynne Marie
CIK: 0001727640
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 10, 2026SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
28.4K shares- - Jun 12, 2025SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - Apr 2, 2025UBX
Unity Biotechnology, Inc.
SaleDirect21.9K shares at avg. $1.03$23K - Mar 28, 2025UBX
Unity Biotechnology, Inc.
AwardDirect65K shares- - Feb 4, 2025UBX
Unity Biotechnology, Inc.
SaleDirect153 shares at avg. $2.23$341.19 - Jan 22, 2025UBX
Unity Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
150K shares- - Nov 4, 2024UBX
Unity Biotechnology, Inc.
SaleDirect136 shares at avg. $1.29$175.44
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Jul 1, 2025 |  INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 28,368 | - | - | Direct |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Apr 2, 2025 |  UBX Unity Biotechnology, Inc. | Sale | 21,867 | $1.03 | $22,523 | Direct |
| Mar 28, 2025 | UBX Unity Biotechnology, Inc. | Award | 65,000 | - | - | Direct |
| Feb 4, 2025 | UBX Unity Biotechnology, Inc. | Sale | 153 | $2.23 | $341 | Direct |
| Jan 22, 2025 | UBX Unity Biotechnology, Inc. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| Nov 4, 2024 | UBX Unity Biotechnology, Inc. | Sale | 136 | $1.29 | $175 | Direct |
1-8 of 8 transactions